SunBio,Inc.

SunBio,Inc., a biotech company develops, produces, and sells biosimilar and biopharmaceutical products, and medical devices based on its technologies of pegylation globally. Its biosimilar products include PEG-filgrastim; and PEG-EPO and uricase which is in preclinical stage. The company offers MucoPEG, a medical device for treatment of dry mouth syndrome; and SynoGEL, a viscosupplement for arthritic Knee.

Its preclinical stage biopharmaceuticals candidates target brain stroke and chronic anemia. It also manufactures and sells PEG derivatives. Founded in 1997, the company is headquartered in Gunpo-si, South Korea.